ERIS Lifesciences Ltd
ERIS Lifesciences Ltd Company History
ERIS Lifesciences is engaged in the manufacture and marketing of pharmaceutical products. The Parent Company has a manufacturing plant located in Guwahati, Assam.
2007
Incorporation of the Company
Launched Eris division focused on cardiology and diabetes segment
2007
2008
Launched Nikkos division focused on gastroenterology and orthopedics segment
2008
2009
Launched Adura division focused on cardiology and diabetes segment
2009
2011
Launched Montana division focused on gynecology and pediatrics segment
2011
2012
Launched Inspira division focused on cardiology segment
2012
2013
Awarded 'Competitive Strategy Leadership' award by Frost & Sullivan
Awarded 'Emerging Companies Excellence' award for scalability of business model and managing operational efficiencies by Business Today and Yes Bank
2013
2014
Launched Victus division focused on anti-diabetes segment
Set up Assam Facility by the Company
2014
2015
Launched Eris 2Â division focused on pain management segment
2015
2016
Acquired 40 registered and unregistered trademarks from Amay Pharmaceuticals Private Limited (now, Aprica Pharmaceuticals Private Limited)
Acquired 100.00% of the outstanding equity shares of Aprica Healthcare Private Limited
Acquired 75.48% of the outstanding equity shares of Kinedex Healthcare Private Limited
2016
2017
Acquired the trademarks ÂUNIONÂ, ÂREUNIONÂ and ÂBON UNIONÂ
2017
2022
Eris Enters Dermatology Therapy Through The Acquisition Of Oaknet Healthcare For Inr 6,500 Mn.
2022
2023
""Eris announces the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics in India"".
2023
